infected with CRE causing 610 deaths annually. 1 Carbapenem resistance is manifested either due to production of carbapenemase enzymes or due to noncarbapenemase mechanisms, for example, alterations in porin channels, mutation in the expression of efflux pumps, or AmpC production. 3 In addition, these isolates often carry other non-β-lactam resistance determinants that give rise to multi-drug-resistant and pan-drug-resistant isolates. 4 Rapid and accurate identification of CRE is crucial not only to reduce the mortality and morbidity, but also to implement infection control measures. The presence of multiple resistance mechanisms among
CREs makes their identification difficult. 5 Currently, several phenotypic tests (e.g, Carba NP test, MHT, CHROMagar, modified carbapenemase inhibition method [mCIM] , and Blue-Carba [BCarba] ) and molecular methods are available for the detection of CRE. However, all these methods have their own limitations in terms of sensitivity, specificity, rapidity, cost-effectiveness, and availability of laboratory facility.
Here, in this study we tried to develop an iCarba NP test for rapid and accurate identification of CP-CRE. We also tried to evaluate its performance with other available phenotypic methods cCarba NP (RAPIDECw CARBA NP), BCarba, MHT, and CHROMagar.
| MATERIAL S AND ME THODS
A prospective study was conducted with 40 nonrepeating
Enterobacteriaceae isolates over a period of 3 months (from November 2016 to January 2017). All the isolates were phenotypically identified by the MALDI-TOF (BioMerieux, Durham, NC, USA). 
| Screening test for CRE

| In-house Carba NP
The iCarba NP test was performed using the following method. Two solutions were prepared.
| Solution A
One microliter solution (made up of 3 mg of imipenem monohydrate No color change was considered as negative. Any color change in solution B was considered as invalid result 6 ( Figure 1 ).
| Commercial Carba NP (cCarba NP)
The RAPIDEC CARBA NP test was performed and interpreted according to the manufacturer's instructions.
| BCarba
The BCarba test was performed as follows. 
| Test solution
Test solution was prepared by mixing 3 mg of imipenem monohydrate in 1-mL of 0.04% bromothymol blue solution containing 0.1 mmol/L ZnSO 4 and adjusted to pH 7. 
| Control solution
| Modified Hodge test
| Statistical analysis
The performance of all the assays was calculated in terms of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Kappa value was calculated to check the inter-rater agreement between all the assays. Considering PCR as gold standard, the sensitivity and specificity of all the phenotypic assays were calculated (Table 1) . Our methodology for iCarba NP is a modification of the original test process described in CLSI in terms of increasing the inoculum size and additional incubation step after the addition of protein extraction reagent. The sensitivity of the phenotypic methods in this study ranged from 63.6% to 96.9%. CHROMagar was observed to have the highest sensitivity followed by the cCarba NP. Both cCarba NP and iCarba NP had highest specificity in comparison with other assays. The performance of iCarba NP was comparable to cCarba NP. 
| RE SULTS
| D ISCUSS I ON
The prevalence of CRE is increasing worldwide causing serious community-acquired and nosocomial infections. Carbapenem resistance is exhibited by two main mechanisms, firstly due to the presence of carbapenemase enzyme, and secondly due to the loss of porin function or expression in the efflux pumps. 2 Identification of CP-CRE can be made by several phenotypic methods. This includes rapid colorimetric-based assays (Carba NP test); growth-based assays (MHT), carbapenem hydrolysis assays; and immunochromatogenic assays. Molecular methods such as PCR and sequencing can also be used for the detection of carbapenemase genes, but less commonly practiced being costly and need good laboratory facility. 9 Among the carbapenemases, bla NDM-1 gene was observed to be present in both the groups of patients with or without history of intake of antibiotics. Hence, the presence of bla NDM-1 gene may not be directly related to previous antibiotic intake. Carba NP is a colorimetric assay based on enzymatic hydrolysis of the β-lactam ring of carbapenem group of drugs. Sensitivity and specificity of this 23 Although reports showed specificity of 98%-100% for Carba NP tests, specificity in the current study was found to be lower. Our result was concordant with the results by Thomson et al. 24 Specificity of all the phenotypic tests was found less in comparison with published reports. 9, 22 It might be due to the presence of other carbapenemase genes apart from the five genes used in the study. Among all the phenotypic tests, CHROMagar and both the Carba NP tests showed high sensitivity and specificity and hence can be used as screening tool to detect production of CP-CRE.
Sensitivity of MHT observed least among all the assays. Our study result showed the presence of NDM-1 and IMP-like carbapenemases in higher amount gives faster positive result than low hydrolyzing enzymes such as OXA-48. The result of time to positivity of various Carba NP in our study was in concordance with the published literature. 25 Comparing the cost, the iCarba NP test was observed 10 times cost-effective than cCarba NP test.
| CON CLUS ION
Among the available phenotypic tests, CHROMagar was observed the most sensitive and specific followed by Carba NP test for detection of CP-CRE. The performance of iCarba NP was comparable with cCarba NP test and was able to differentiate CP-CRE from other carbapenem-resistant isolates. Both the Carba NP tests were found rapid, accurate, and easy to perform and interpret the result. Hence, it can be used as screening test for the rapid detection of CP-CRE in clinical settings.
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